Korea Joongang Daily
Korea JoongAng Daily

[INTERVIEW] Novel immunotherapy gives hope to blood cancer patients

A novel immunotherapy may offer hope for blood cancer patients with no previous options. PeproMene Bio's BAFF-R CAR-T treatment is showing promising results with no side effects.

2023-10-20

GS Caltex and LG Chem sign MOU for joint biodegradable business

GS Caltex and LG Chem agreed on a joint biomaterial business for the world’s first commercial production of next-generation biodegradable plastic feedstock.

2023-10-13

U.S. subsidiary of CHA Biotech appoints new executives

Matica Biotechnology, a US subsidiary of CHA Biotech, has appointed Laura Parks as EVP of commercial operations and Heather Sugrue as VP of alliance management to enhance its cell and gene therapy contract manufacturing capabilities.

2023-09-19

Matica Biotechnology introduces self-developed cell line

Matica Biotechnology, a U.S. subsidiary of CHA Biotech, introduced its self-developed cell line MatiMax at the annual BIO International Convention 2023 (BIO USA) taking place in Boston.

2023-06-07

CHA Biotech sees big future in CDMO market

As global pharmaceutical and bio groups increase the outsourcing of production in the contract development and manufacturing organization (CDMO) market, CHA Biotech is focusing on innovation in the cell and gene treatment manufacturing sector.

2022-12-20

Korea's bourse operator allows Sillajen to resume stock trading

Korea's bourse operator on Wednesday decided to allow scandal-ridden bio firm Sillajen to resume its stock trading after more than two years of suspension.

2022-10-12

[INTERVIEW] ABL Bio has grown from go-getter to go-to company

For ABL Bio CEO Lee Sang-hoon, this year’s BIO International Convention (BIO USA) is totally different from what it used to be three years ago.

2022-06-20

Hyundai Oilbank eyes 'white biotechnology' as future growth engine

Hyundai Oilbank will focus on “white biotechnology" in an attempt to make its business more sustainable, the oil refiner said Wednesday.

2022-05-11

Incheon mayor seizes opportunity in bio cluster

The Covid-19 pandemic has put cities around the world in lockdown, but for the port city of Incheon, the pandemic opened up a window of opportunity to become the Asian hub for the bio industry.

2022-01-06

Matica to work with Germany's Sartorius on viral vector production

Matica Biotechnology, a wholly owned subsidiary of CHA Biotech, signed an agreement with Göttingen, Germany’s Sartorius, to cooperate on developing advanced technologies for large-scale viral vector production.

2021-10-19